1. Introduction {#s0005}
===============

Central venous catheter (CVC) is an indispensable tool for managing critically ill patients; such as hemodialysis and cancer patients ([@b0085]). In spite of its crucial role, it poses patients to a high risk of catheter-related bloodstream infections (CRBSIs) resulting in high rates of morbidity, mortality and increased cost ([@b0100]). Catheters could be contaminated via four different routes including; migration of skin normal flora along the external surface at the insertion time, catheter hub contamination during catheter manipulation, hematogenous seeding of the catheter from another infected site, and the contamination of the catheter lumen with contaminated fluids ([@b0250]). The commonest culprits in CRBSI are *P. aeruginosa*, *S. aureus, E. coli, K. pneumoniae, Acinetobacter baumannii*, *Enterobacter spp., Serratia spp.*, and *Candida spp*. ([@b0115], [@b0250]). CRBSIs due to central venous catheterization are up to 64 times greater than peripheral venous catheters ([@b0085]). Such infections are initiated by biofilm formation ([@b0090]), where the inert catheter surface acts as a substratum for microbial biofilms ([@b0120]).

A biofilm is a microbial community of sessile bacteria encased in a self-produced matrix of exopolysaccharides, protein, and eDNA ([@b0040]). Biofilm formation process encompasses sequential steps; starting with attachment to a surface leading to micro-colony formation, giving rise to three-dimensional structures and ending up; after maturation; with detachment ([@b0245]). Biofilm bacteria are highly resistant to antibiotics and the human immune system ([@b0060], [@b0245]). CVC is extraluminally colonized by cutaneous microorganisms in short-term catheterization (\<10 days). Meanwhile, intraluminal colonization; from the hub; is common with long-term catheterization (\>10 days) ([@b0100]). Preventive measures such as insertion under aseptic conditions and insertion site care mainly decrease the extra-luminal colonization, meanwhile antibiotic lock therapy (ALT) is recommended for eradicating intraluminal biofilm through filling the catheter lumen with a highly concentrated (100--1000 times MIC) antibiotic solution and leaving it indwelling (lock) for hours or days to eradicate biofilms ([@b0120]). In spite of proven efficiency in eradicating microbial biofilms, the emergence of resistant strains due to ALT was reported by many investigators ([@b0045], [@b0120]). Moreover, ALT failed to treat infections caused by *S. aureus, P. aeruginosa* or *Candida* spp. ([@b0030], [@b0080])*.*

In the era of antibiotic resistance, natural products could substitute for antibiotics to treat infections with low potential for resistance. Garlic (Allium sativum) was put to focus as a weapon against multi-drug resistant pathogens ([@b0095]). In addition to many other compounds, allicin is the main bioactive antibacterial compound in garlic ([@b0095]). The ability of garlic essential oils to penetrate the microbial cellular membranes and the sub-cellular organelles membranes was well documented ([@b0155]). Intracellularly, it interferes with RNA synthesis and blocks vital enzymes; within bacteria, fungi and viruses; such as cysteine proteinases, alcohol dehydrogenases, acetate kinase, phosphotransacetyl-CoA synthetase and thioredoxin reductases ([@b0215]). This explains the broad-spectrum activity of garlic against different bacterial, viral and fungal infections with low potential for developing bacterial resistance because of the multiple sites of action ([@b0220]). Its potent antimicrobial and antibiofilm activities were reported against a big number of MDR Gram-positive and Gram-negative bacteria in addition to *Candida* spp. ([@b0170], [@b0180], [@b0210]), including resistant strains of *Helicobacter pylori, E Coli-0124, E Coli-0111, Salmonella* spp.*, Shigella spp.* and *S. aureus* ([@b0010], [@b0020]). Even fatal diseases such as anthrax and tuberculosis were found to be sensitive to garlic components ([@b0010]). The aim of this study was directed to assess the antibacterial and antibiofilm activities of fresh garlic extract (FGE) against MDR bacterial species in both *in-vitro* and *in-vivo* models to assess its potential use in antibiotic lock therapy.

2. Materials & methods {#s0010}
======================

2.1. Test strains, culture conditions, and inoculum preparation {#s0015}
---------------------------------------------------------------

Five strong biofilm-forming MDR clinical isolates namely, *Pseudomonas aeruginosa (P. aeruginosa), Klebsiella pneumoniae (K. pneumoniae), Serratia marscens (S. marscens) and Methicillin-resistant Staphylococcus aureus (MRSA),* were used. Test strains were isolated from the catheter tips of central venous catheters collected from oncology patients within an Egyptian University Hospital. Strains were identified using the VITEK 2® system and stored in tryptic soy broth (Oxoid, England) with 20% (vol/vol) glycerol at −80 °C. Their ability for *in-vitro* biofilm formation was assessed by the crystal violet (CV) staining assay in tissue culture plates (TCP) as previously described ([@b0240]). For propagation, bacteria were spread over sheep blood agar, incubated aerobically at 37 °C/24 h. Colonies were suspended in tryptic soy broth (TSB), incubated till the logarithmic growth phase, then standardized according to EUCAST ([@b0110]).

2.2. Preparation of fresh garlic extract (FGE) {#s0020}
----------------------------------------------

Fresh garlic bulbs were purchased from a public food store, peeled, and homogenized using sterile mortar and pestle. Then filtered through a cheesecloth, centrifuged at 12,000 rpm for 10 min and filtered twice through a 0.22 μm filter (Millipore TM; MA, USA) to obtain raw garlic extract. This represented the 100% concentration that was then diluted with sterile distilled water to get concentrations of 75%, 50%, and 25%, then stored in the refrigerator for subsequent uses ([@b0130]).

2.3. Testing the antibacterial activity of FGE {#s0025}
----------------------------------------------

FGE at concentrations of 100%, 75%, 50%, and 25% were tested for antibacterial activity by the agar well diffusion assay as described elsewhere ([@b0015]) using chloramphenicol (32 µg/mL) and sterile distilled water as positive and negative controls, respectively. Inhibition zones with diameter less than 12 mm were considered as negative for antibacterial activity.

2.4. Determination of the minimal inhibitory concentration (MIC) of FGE against test strains {#s0030}
--------------------------------------------------------------------------------------------

The MIC of FGE against test strains was tested by the microdilution method according to the guidelines ([@b0110]) using two-fold serial dilution (1--1024 µg/mL), where untreated bacterial broth and uninoculated broth were used as positive and negative controls, respectively.

2.5. Estimation of the antibiofilm activity of sub-inhibitory concentrations of FGE {#s0035}
-----------------------------------------------------------------------------------

To assess the antibiofilm efficiency of FGE, the crystal violet assay was used as previously described ([@b0275]) with minor modifications. Briefly, bacterial isolates were exposed to FGE at ^1^/~2~, ^1^/~4~ or ^1^/~8~ MIC prepared in TSB supplemented with 1% glucose (TSB/1% glucose) in a sterile tissue culture plate (TCP), 200 μl each using untreated inoculated broth (cells + broth) as growth control. Un-inoculated FGE-free and un-inoculated FGE-supplemented media were used to define the background OD~570~ values. Plates were aerobically incubated on a shaker (100 rpm) at 37 °C for 24 h. Culture media were then removed, wells were washed twice with sterile phosphate buffer saline (PBS, pH 7.2)., fixed with methanol, stained for 20 min with 1% w/v crystal violet, washed and then solubilized by 95% ethanol. The OD~570~ was determined using ELISA microplate reader ELX800 (Biotek/USA). The antibiofilm activity was calculated as the percentage of reduction using the previously described formula ([@b0165]) as follow:$$\lbrack(OD\mspace{900mu} Growth\mspace{900mu} control - OD\mspace{900mu} Sample)/OD\mspace{900mu} Growth\mspace{900mu} control\rbrack \times 100$$

2.6. Testing for the antibiofilm efficiency of test concentrations against test strains {#s0040}
---------------------------------------------------------------------------------------

To assess the efficiency of test concentrations of FGE in inhibiting biofilm formation, the above-mentioned protocol was used with the exception of replacing the sub-MICs of FGE with test concentrations (100%, 75%, 50% & 25%). To assess the biofilm eradication efficiency, mature biofilms were first formed by inoculating wells with a heavy bacterial suspension (1 × 10^8^ CFU/ml) prepared in TSB/1% glucose, then aerobically incubated in an incubator shaker at 37°/48 h. Media were discarded and wells were washed with sterile PBS (pH 7.2). Biofilms were then treated with test concentrations and aerobically incubated at 37°/24 h. Biofilms were detected by crystal violet staining and quantified as mentioned above. All tests were performed in independent triplicates.

2.7. *In-vitro* lock models {#s0045}
---------------------------

Test concentrations were evaluated as lock solutions for either inhibition or eradication of bacterial colonization of CVC. For assessing the inhibitory efficiency, the previously described method ([@b0035]) was used with minor modifications. Briefly; 3 mm segments of a 4-French Polyurethane (PU) CVC (Amecath, Egypt) were inserted into a 24-well Costar plate containing 0.5 ml test concentrations of FGE in TSB/1% glucose along with bacterial cultures and incubated aerobically at 37° for 24 h in a shaker (100 rpm). Segments were then picked up, washed and prepared for viable counting. Where adhered cells were released via sonication using a VCX-400 sonicator (Sonics & Materials Inc., Danbury, CT, USA) (120 s, 30% cycle, pulse 3.5 s), vortexed, serially diluted, and spread over Mueller-Hinton agar. The eradication efficiency was assessed according to Ko et al. ([@b0135]) with modifications. CVC sheets were incubated in human plasma at 37 °C for 24 h ([@b9000]). Plasma was then replaced by microbial suspensions (1x10^8^ CFU/ml) of test strain in TSB/1% glucose in an incubator shaker (100 rpm) at 37 °C/5 days. Sheets were then picked up, washed with PBS, placed in 10 ml of FGE test concentration. Garlic-free broth was used as a control. After 1, 3, 5, 7 & 10 days, segments were processed for viable counting as mentioned above. Experiments were performed in triplicates. Scanning electron microscopy (SEM) was used for confirming the effectiveness of garlic lock in eradicating biofilms of *P. aeruginosa and MRSA* according to the published protocol ([@b0145]). Briefly; segments were fixed for 2 h at 4 °C with 3% glutaraldehyde, then dehydrated in a graded ethanol series (30%, 50%, 70%, 90% and 100%, 10 min each), dried, sputter coated with gold and observed with a high-resolution scanning microscope (JEOL-Japan Electron Optics Laboratory) at 30 KV.

2.8. *In-vivo* antimicrobial activity of FGE {#s0050}
--------------------------------------------

### 2.8.1. Animals {#s0055}

Female albino mice (weight 25--30 g) were acclimatized for two weeks in a temperature and light-controlled room (25 °C, 12-h light/dark cycle) in the animal house at the NCRRT with free access to water and food.

### 2.8.2. Ethical considerations {#s0060}

All procedures in this study were approved by the Ethics Committee, Faculty of Pharmacy, Cairo University (MI-1082).

### 2.8.3. Selection of garlic doses {#s0065}

The corresponding MIC values against *P. aeruginosa* and MRSA were prepared in human serum, then 20 µl were inoculated on a blank filter paper disk, placed on inoculated agar, incubated at 35--37 °C for 24 h and the diameter of the inhibition zone was determined. At the same time, mice were intraperitoneally injected with different doses (50, 100, 200 & 400 mg/kg) of FGE, 2-hours post-injection; and at 6-hours interval over 24 h; the antibacterial activity of serum garlic was estimated by the Kirby-Bauer method as previously described ([@b0050]). Inhibitions zones were compared to that obtained by the disc holding the MIC.

### 2.8.4. Bacterial inoculum and induction of infections {#s0070}

*P. aeruginosa* and *MRSA* were grown in TSB/1% glucose till the log phase. Bacterial concentration was determined by measuring the OD~600~ and comparing to the growth curve constructed by plotting OD~600~ of bacterial suspension and colony-forming units (CFU) plated on Mueller-Hinton agar. Different bacterial doses (10^6^-10^12^ CFU) were injected into the animals. Over a 24 h period and at 6-hours intervals, animal's body temperatures were measured and blood samples were collected from the tail and processed for total white blood cells (WBCs) count.

Mice were divided into 12 groups of 7 each, six groups were allocated for each test strain. Out of which, group A was used as a negative control (saline-treated). Groups B through F were injected intraperitoneally with the corresponding infective dose and categorized as follow, group B was used as a positive control (infected and treated with normal saline), groups C and D were infected and simultaneously treated with either 100 mg/kg or 200 mg/kg of FGE, respectively. To ascertain metastatic infections and assess the efficiency of FGE in eradicating tissue biofilms, the other two groups were treated after 48 h with 100 mg/kg (group E) or 200 mg/kg of FGE (group F). Extra two groups were only injected with FGE, 100 mg/kg (group G) or 200 mg/kg of FGE (group H) without being infected for estimating the toxicity profiles. Animals received treatments once a day for seven days and observed for any physical change during the treatment period.

### 2.8.5. Terminal harvest and processing of blood and tissues {#s0075}

#### 2.8.5.1. In-vivo antimicrobial efficiency of garlic treatment {#s0080}

One day after the end of the experiment, mice were euthanized under aseptic conditions, blood samples and organs (heart, liver, kidney, and spleen) were collected from infected groups. Blood and minced body organs (1 g each) were cultured for detecting the total viable count by the spread plate technique ([@b0230]), any growth was recorded.

#### 2.8.5.2. Evaluation of toxicity profile of garlic {#s0085}

Blood and tissue samples from groups A, G &H were assessed for biochemical, hematological and histopathological changes. Biochemical profiles of heart, kidney, and liver functions were assessed by measuring the serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), albumin, bilirubin, total protein, creatine kinase (CK-MB), lactate dehydrogenase (LDH), creatinine and blood urea. All tests were performed according to the standard methods ([@b0235]). Hematological parameters; hemoglobin, hematocrit (HCT), red blood cells (RBC), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), white blood cell (WBC), granulocyte count and lymphocytes were determined using Animal Blood Counter-ABC vet (Horiba ABX, France).

For histopathological studies, at autopsy, one gram from liver, heart, lung, kidney, and spleen was fixed in 10% formaldehyde; dehydrated through ascending grades of alcohol, cleared in xylene, wax-impregnated and embedded in paraffin wax. They were sectioned using microtome (Leica RM 2125, Leica Biosystems Nussloch GmbH, Germany) and stained with haematoxylin and Eosin and examined for histopathological changes using light microscope (Olympus BH-2, Olympus, Tokyo, Japan) ([@b0070]).

2.9. Statistical analysis {#s0090}
-------------------------

Experiments were performed in triplicates. All data are expressed as means ± standard deviation (mean ± SD). ANOVA test (SPSS, version 18) was used for comparing data. P \< 0.05 was considered significant.

3. Results {#s0095}
==========

3.1. Antibacterial activity of FGE {#s0100}
----------------------------------

With the exception of *MRSA* and *K. pneumoniae,* inhibition zone measurement showed a significant (P value \<0.001) higher antibacterial activity with all test concentrations; compared to chloramphenicol; that was concentration and strain-dependent ([Fig. 1](#f0005){ref-type="fig"}a). The MIC values were found to be 16 mg/ml for *E. coli* and *P. aeruginosa*, 32 mg/ml for *S. marscens* and *MRSA*, while *K. pneumoniae* recorded 64 mg/ml.Fig. 1(a) Antibacterial activity of FGE, (b) Antibiofilm efficiency of FGE at sub-MICs against test strains, Data are presented as means of three trials (n = 3), error bars represent SD.

3.2. Estimation of the antibiofilm activity of FGE {#s0105}
--------------------------------------------------

Crystal violet staining in tissue culture plate (TCP) was used for evaluating the antibiofilm efficiency of FGE. FGE at sub-inhibitory concentrations exhibited a concentration (P \< 0.001) and strain-dependent (P \< 0.05) antibiofilm activity with the highest efficiency observed with ^1^/~2~ MIC against all test strains with predominance against *S. marscens* (66%) followed by *K. pneumoniae (61%), E. coli (57%)* and *MRSA* (56%). However, *P. aeruginosa* recorded the lowest inhibition rate (55%) ([Fig. 1](#f0005){ref-type="fig"}b).

Additionally, test concentrations (100%, 75%, 50% & 25%) showed concentration and strain-dependent effectiveness in inhibition and eradication of biofilms (P-value \< 0.001). Where the inhibitory effect of pure FGE (100%) recorded inhibition rates exceeded 90% with test strains as follow; 98.50, 96.10, 95.30, 95.30 &93.70% with *K. penumoniae, S. marscens, E. coli, MRSA* and *P. aeruginosa,* respectively. While at a concentration of 25%, FGE exhibited inhibition rates of 53.60, 44.70, 50.60, 50.50 and 48.40%, respectively ([Fig. 2](#f0010){ref-type="fig"}a). On the other hand, when evaluating [Fig. 2](#f0010){ref-type="fig"}(b), it was observed with the concentration of 100% that garlic was able to eradicate over 70% of the mature biofilm *of S. marcescens*, whereas for *P. aeruginosa*, its activity was not very accentuated.Fig. 2Efficiency of test concentrations of FGE in: Inhibition of biofilm in tissue culture plates (a) Eradication of mature biofilms in tissue culture plates (b), and Inhibition of biofilms on Polyurethane sheets (c). Data are presented as means of three trials (n = 3), error bars represent SD.

3.3. *In-vitro* lock models {#s0110}
---------------------------

Upon evaluating the chemoprotective efficacy of garlic lock against catheter colonization, pure garlic almost inhibited biofilm formation by test strains on the catheter sheets after 24 h. however, low growth was detected with *P. aeruginosa* and *MRSA*. While concentration-dependent differences (P value \< 0.001) in inhibition rates were observed with other concentrations ([Fig. 2](#f0010){ref-type="fig"}c). Similarly, the chemotherapeutic efficacy of FGE showed significant concentration and time-dependent variations among test strains (P-value \< 0.001). Where the average initial biofilm count was 7.6 × 10^6^, 9.2 × 10^9^, 2.4 × 10^10^, 1.3 × 10^7^ and 4.3 × 10^6^ CFU/segment for *E. coli, P. aeruginosa*, *K. penumoniae, S. marscens* and *MRSA*, respectively. Pure garlic extract (100%) completely eradicated biofilms formed by *S. marscens, K. penumoniae and E. coli* after one day lock*.* Meanwhile*, P. aeruginosa and MRSA* required three days for complete eradication*.* The lowest concentration (25%) achieved zero survivors after 7 days lock period with all test strains, except *P. aeruginosa* required 10 days ([Fig. 3](#f0015){ref-type="fig"}).Fig. 3Efficiency of garlic lock in the eradication of biofilms by test strains at different lock periods. Data are presented as means of three trials (n = 3), error bars show the SD.

Garlic locks induced morphological changes in bacterial biofilms of *MRSA* and *P. aeruginosa;* as revealed by the SEM*;* comprising cell-shape deformation and cellular breakdown. Untreated samples showed clumps of heavy biofilms composed of aggregates of bacterial cells embedded in a matrix. However, sheets treated with 100% FGE showed clean surface almost free from any adhered cells after a three-days lock period, representative images for SEM are shown in [Fig. 4](#f0020){ref-type="fig"}.Fig. 4SEM micrographs showing the effects of the highest (100%) and the lowest (25%) garlic lock concentrations on biofilms of *MRSA* and *Pseudomonas* at different lock periods.

3.4. Bacterial inoculum and induction of infections {#s0115}
---------------------------------------------------

Doses of 1.0 × 10^6^ and 1.0 × 10^8^ CFU were found enough to induce infections by *P. aeruginosa* and *MRSA*, respectively after 12 h as confirmed by leukocytosis.

3.5. *In-vivo* antimicrobial activity of FGE {#s0120}
--------------------------------------------

By comparing the inhibition zones achieved by the MIC and test doses, doses of 100 and 200 mg/kg produced comparable results sustained for 24 h. Systemic infections with *P. aeruginosa* and *MRSA* were induced in mice via intraperitoneal injection. In case of *P. aeruginosa*, groups C and D recorded survival rate of 85.7%; where one mouse died after 4 and 1.5 h, respectively. For groups E and F; in spite of the high fever (40.2 ± 0.9 C^0^) developed; their body temperature dropped to (36.5 ± 0.44 C^0^) after being treated and survived till the end of the experiment. However, the untreated group (B) showed an increase in their body temperatures, and recorded a 100% mortality by the 5th day. In case of *MRSA,* all animals in groups C and D survived till the end of the experiment. Groups E and F developed fever (39.2 ± 0.54 C^0^), but dropped to (35.6 ± 0.24 C^0^) after treatment and survived till the end of the experiment. However, only one mouse (14.3%) survived in group B.

One day after the end of the treatment period, blood samples and tissues were harvested for viable counting from survived animals. No growth was detected in the blood or tissues of groups C, D or F in both infections. However, for E groups, low growth levels were detected within the tissues, but their blood was growth-free ([Fig. 5](#f0025){ref-type="fig"} a &b).Fig. 5Log surviving cells within blood and organs of animals in group E of: (a) *P. aeruginosa*, and (b) MRSA. Data are presented as means (n = 3), error bars represent SD.

By comparing the biochemical parameters of groups G&H with that of the control (group A), both doses exhibited cardio and hepatoprotective effects as noticed by the significant (P-value \< 0.001 & \<0.05) drop in the cardiac and hepatic biomarkers. No alteration in the kidney biomarkers was recorded, except for the blood urea which significantly decreased upon garlic treatment (P-value \< 0.005) ([Table 1](#t0005){ref-type="table"}). Upon evaluating the hematological parameters, no significant alterations (P value \> 0.05) were found in the tested parameters ([Fig. 6](#f0030){ref-type="fig"}).Table 1Serum biochemical parameters in mice treated with FGE.ParameterControl100 mg/kg200 mg/kgCK-MB624 ± 1244 ± 3[\*](#tblfn1){ref-type="table-fn"}615 ± 1[\*](#tblfn1){ref-type="table-fn"}LDH171.9 ± 1174 ± 1.5[\*](#tblfn1){ref-type="table-fn"}159 ± 0.9[\*](#tblfn1){ref-type="table-fn"}Creatinine1 ± 0.00.6 ± 0.03[\*](#tblfn1){ref-type="table-fn"}0.95 ± 0.0Blood urea29 ± 122 ± 0.8[\*](#tblfn1){ref-type="table-fn"}24 ± 1[\*](#tblfn1){ref-type="table-fn"}Serum Albumin3.2 ± 0.03.6 ± 0.362.8 ± 0Bilirubin0.27 ± 0.010.25 ± 0.00.29 ± 0.01AST (SGOT)36 ± 131 ± 1.6[\*](#tblfn1){ref-type="table-fn"}27 ± 1[\*](#tblfn1){ref-type="table-fn"}ALT (SGPT)47 ± 142 ± 0.5[\*](#tblfn1){ref-type="table-fn"}39 ± 0[\*](#tblfn1){ref-type="table-fn"}[^1][^2]Fig. 6Effect of garlic on the hematological parameters. Data are presented as means of three trials (n = 7).

3.6. Histological investigation {#s0125}
-------------------------------

The H & E staining showed no histological changes in the architecture of the heart, spleen, lung, kidneys or liver of animals treated with tested doses; when compared to the control ones ([Fig. 7](#f0035){ref-type="fig"}).Fig. 7Light micrographs of the mice organs showing the control and treated ones (X400).

4. Discussion {#s0130}
=============

Natural organosulfur compounds within garlic provide the basis for innovative sources of novel antibiotics against resistant pathogens ([@b0105]). This study was directed to assess the potential use of garlic in the prevention and treatment of CVCRIs. Where FGE was *in-vitro* evaluated; in relation to its antibacterial activity; against five MDR clinical bacterial strains. Additionally, the *in-vivo* antibacterial activity was further evaluated against *P. aeruginosa* and *MRSA* infections. We also highlighted the potential toxic effects of garlic on mice. We prepared fresh raw garlic extract to be used, as its antimicrobial activity was reported to be superior to its isolated compounds ([@b0260]). In agreement with others ([@b0020]), FGE showed potent antibacterial activity that was concentration and strain-dependent. Among the five test strains, the highest MIC value was recorded with *K. pneumoniae*. Its capsule might block the access of plant essential oils to the fragile inner membrane ([@b0065]). Garlic allicin interferes with crucial bacterial enzymes through the inactivation of thiol group ([@b0215], [@b0220]). Other investigators ([@b0175], [@b0190]) didn't record prominent antibacterial activity for either the aqueous or alcoholic extract of garlic by the disk diffusion methods. However, many factors could affect the results; such as the plant origin, period of the year, extraction methods, microbial test strains ([@b0020], [@b0190]), testing methodology (agar well, filter paper, macro-broth dilution or micro-broth dilution) and storage conditions. The antibacterial activity of fresh garlic was found to be superior to garlic powder, garlic oil and butylated hydroxyanisole ([@b0225]). Drying temperature and time might also affect the results ([@b0205]). Finally, testing strains might have variable results; clinical strains are more resistant than standard ones ([@b0010]).

Biofilm plays a vital role in pathogenicity, virulence and antimicrobial resistance of microbial pathogens ([@b0020], [@b0245]). We found that sub-MICs of FGE showed an evident antibiofilm activity in a concentration-dependent fashion. Allicin at sub-MIC levels was found to inhibit adherence and biofilm ([@b0195]). Our findings revealed that the inhibitory effect was more prominent than the eradication effect on mature biofilm. However, both effects on biofilm were concentration and strain-dependent. These findings agree with that of Mohsenipour ([@b0175]). In the same way, the antibiofilm activity of garlic on Gram-positive and Gram-negative bacteria under chemopreventive and chemotherapeutic conditions was reported ([@b0180], [@b0215]). The higher preventive effect could be due to the bactericidal effect of garlic on the planktonic phase and subsequently, interference with the initial attachment step which is essential for biofilm formation ([@b0180]). Additionally, allicin down-regulates biofilm genes expression ([@b0270]), reflecting the chemotherapeutic efficiency of garlic on mature biofilm.

For the *in-vitro* evaluation of garlic lock, PU catheter sheets were used because PU; compared to other biomaterials; is more susceptible for microbial colonization ([@b0265]). Generally, the results of the lock model matched with that of the CV assay in TCP regarding the preventive and therapeutic efficiencies of garlic, where pure garlic extract showed the highest efficiency against biofilms in both cases. Similar observations were documented by others ([@b0165], [@b0175]). Morphological deformation noticed by the SEM could be due to the interaction of allicin with the cellular thiol groups ([@b0075]). The increased exposed surface area of bacterial rods might explain the fragmentation noticed in *Pseudomonas.* Other investigators documented similar observations with other bacilli ([@b0160]).

Because bacterial behaviors, as well as the effectiveness of antimicrobial agents, might differ *in-vivo* from that of *in-vitro* ([@b0260]), we designed an *in-vivo* model to assess the effectiveness of FGE in managing infections. Systemic infections were induced in mice, then treated daily with 100 or 200 mg/kg of FGE for seven days. A 7-day catheter-lock period was reported to be an effective period for managing CVC-related infections ([@b0185]). The *in-vivo* results demonstrated promising antibacterial effectiveness for FGE. The early death occurred in *Pseudomonas-*infected mice; simultaneously treated with garlic; demonstrates the potent antibacterial activity of garlic on planktonic cells that provoked an inflammatory response and endotoxic shock due to massive cell destruction and the release of endotoxins ([@b0055]). Being less sensitive to lipopolysaccharides (LPS), mice require a high dose to elicit an inflammatory response ([@b0200]), this indicates the high bioburden within infected mice. The *in-vivo* antimicrobial activity of garlic against *MRSA* ([@b0125]) and *P. aeruginosa* ([@b0025]) was previously documented. Moreover, the prophylactic garlic treatment was found to be associated with reduced mortality ([@b0025]). Biofilm-related infections could affect internal organs ([@b0150]). We established such infections by delayed garlic treatment 2-days post-infections. In spite of the complete clearance of infecting pathogens from the bloodstream, few cell numbers were detected in the organs in both infections treated with 100 mg/kg. This might recommend a longer treatment duration to completely eradicate organs biofilm. However, this low number explains the antibiofilm activity of garlic treatment; especially organs biofilms were completely eradicated when treated with 200 mg/kg. Tsao and colleagues ([@b0255]) found that oral garlic treatment of *MRSA*-infected mice reduced bacterial bioburden within internal organs. Additionally, the *in-vivo* antibiofilm activities against *Pseudomonas spp*. as well as *Staphylococcus spp*. were reported ([@b0025], [@b0280]). Moreover, garlic exhibited antibiofilm activity in a burn model against Gram-negative and Gram-positive bacteria ([@b0180]). On the contrary, *A. sativum* failed to eradicate *MRSA* infections in induced granulation tissues in rats upon oral administration of 100 or 400 mg/kg ([@b0260]). The discrepancies may be due to the short treatment durations used by the investigators (6--24 h), especially they recorded an *in-vitro* antimicrobial activity against the test strains. This supports our explanation for the low detected CFU in organs.

The toxic effects of garlic could be a barrier against its potential usefulness, so we assessed the potential toxic effects of the two selected doses at the biochemical, hematological and histological levels. Regarding the biochemical profile, a cardioprotective effect was found with both doses, where a significant lowering in the cardiac enzymes was reported; compared to the control. This could be due to the cardiac glycosides within garlic ([@b0070]). In agreement with others, garlic treatment exhibited dose-dependent hepatoprotective effect as exhibited by the drop in liver biomarkers ([@b0070]) which could be due to the antioxidant nature of garlic ([@b0105]). Garlic doses up to 350 mg/kg were reported to have protective effects on liver, heart, and kidneys ([@b0070]). No changes in the hematological parameters were recorded in our study. Garlic dosing at 300 mg/kg was previously reported to be safe for use based on the biochemical and hematological investigations ([@b0140]). Finally; and in agreement with others ([@b0070]); no prominent changes in the histological architecture of the heart, lung, kidneys, spleen, and livers were observed in our study, such findings support the biochemical measurements.

5. Conclusions {#s0135}
==============

Considering the results, FGE demonstrated a unique antibacterial activity against clinical pathogenic bacteria; either in the planktonic or biofilm forms; in both *in-vitro* and *in-vivo* models without observed toxic effects. This supports its potential use as a prophylactic and/or therapeutic lock agent against biofilm-associated infections caused by MDR bacteria.

5.1. Recommendations for future researches {#s0140}
------------------------------------------

Despite the breadth of studies on the antimicrobial properties of garlic, there remains a paucity of the *in-vivo* researches and clinical trials. Furthermore, the majority of studies were *in-vitro* performed on mono-species biofilms, so it's difficult to extrapolate the *in-vitro* results to the complex, multispecies biofilms in patients. So, we recommend further *in-vivo* studies on multispecies biofilms on catheter models for verifying the effectiveness of garlic in lock therapy.
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[^1]: Results are presented as means ± SD (n = 7).

[^2]: Indicates a significant reduction in the treated group compared to control.
